High-frequency triazole resistance found in nonculturable aspergillus fumigatus from lungs of patients with chronic fungal disease

Clinical Infectious Diseases

Volumn 52, Issue 9, 2011, Pages 1123-1129

  Denning, David W ^a,b,c,f   Park, Steven ^d   Lass Florl, Cornelia ^e   Fraczek, Marcin G ^b,c   Kirwan, Marie ^a,b   Gore, Robin ^b   Smith, Jaclyn ^b   Bueid, Ahmed ^b   Moore, Caroline B ^c   Bowyer, Paul ^b   Perlin, David S ^b,d  

^a National Aspergillosis Centre   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL DNA; ITRACONAZOLE; POSACONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; CYP51A GENE; DNA EXTRACTION; FUNGUS CULTURE; FUNGUS MUTATION; GENE; IMMUNOCOMPROMISED PATIENT; LUNG ASPERGILLOSIS; LUNG LAVAGE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM; TANDEM REPEAT; VOLUNTEER;

ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; CULTURE MEDIA; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; LUNG; MUTATION; POLYMERASE CHAIN REACTION; PULMONARY ASPERGILLOSIS; SPUTUM; TRIAZOLES;

EID: 79953869925     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir179     Document Type: Article

References (45)

1. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005; 43(Suppl 1): S207-38. (Pubitemid 41038572)
2. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensi-tivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009; 13:936-44.
3. Denning, D, Pleuvry A, Cole D. Global burden of allergic broncho-pulmonary aspergillosis (ABPA) complicating asthma. Thorax 2010; 65(Suppl 4):A155-A155.
4. Aimanianda V, Bayry J, Bozza S, et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 2009; 460:1117-21.
5. Fedorova ND, Khaldi N, Joardar VS, et al. Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus. PLoS Genet 2008; 4:e1000046.
6. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America (IDSA). Clin Infect Dis 2008; 46:327-60. (Pubitemid 351265310)
7. Denning DW, Hope WW. Therapy for fungal diseases: opportunities and priorities. Trends Microbiol 2010; 18:195-204.
8. Martinez M, Cloud G, Chen V, Stevens DA. Itraconazole and am-photericin B resistance 1987-2009 in clinical Aspergillus fumigatus in northern California [Abstract 30]. In: 4th Advances Against Aspergil-losis. Rome: February 4-6th 2010.
9. th 2010.
10. Snelders E, van der Lee HA, Kuijpers J, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5:e219.
11. Howard SJ, Cerar D, Anderson MJ, et al. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15:1068-76.
12. Bueid A, Howard SJ, Moore CB, et al. Azole antifungal resistance in Aspergillus fumigatus-2008 and 2009. J Antimicrob Chemother 2010; 65:2116-8.
13. Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 2009; 9:789-95.
14. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342:756-62. (Pubitemid 30151919)
15. Denning DW, O'Driscoll BR, Powell G, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitisation (SAFS), the FAST study. Am J Respir Crit Care Med 2009; 179:11-8.
16. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature and review. Clin Infect Dis 2003; 37(Suppl 3): S265-80. (Pubitemid 37260464)
17. Camuset J, Nunes H, Dombret MC, et al. Treatment of chronic pulmonary aspergillosis by voriconazole in non-immunocompromised patients. Chest 2007; 131:1435-41. (Pubitemid 46762349)
18. Howard SJ, Pasqualotto AC, Denning DW. Azole resistance in ABPA and Aspergillus bronchitis. Clin Microbiol Infect 2010; 16:683-8.
19. van der Linden JW, Jansen RR, Bresters D, et al. Azole-resistant central nervous system aspergillosis. Clin Infect Dis 2009; 48:1111-3.
20. Pagano L, Caira M, Picardi M, et al. Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality-SEIFEM-C Report. Clin Infect Dis 2007; 44:1524-5. (Pubitemid 46801604)
21. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007; 30:782-800. (Pubitemid 351194841)
22. Warrilow AG, Melo N, Martel CM, et al. Expression, purification and characterization of Aspergillus fumigatus sterol 14-{alpha} demethylase (CYP51) isoenzymes A and B. Antimicrob Agents Chemother 2010; 54:4920-3.
23. Balashov SV, Gardiner R, Park S, Perlin DS. Rapid, high-throughput, multiplex, real-time PCR for identification of mutations in the cyp51A gene of Aspergillus fumigatus that confer resistance to itraconazole. J Clin Microbiol 2005; 43:214-22. (Pubitemid 40096303)
24. Howard SJ, Webster I, Moore CB, et al. Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents 2006; 28:450-3. (Pubitemid 44740492)
25. Standards Unit, Evaluations and Standards Laboratory, Centre for Infections. Investigation of bronchoalveolar lavage, sputum and associated specimens; BSOP57 www.hpa-standardmethods.org.uk/documents/bsop/pdf/bsop57.pdf. Accessed 4 September 2010.
26. De Pauw B, Walsh TJ, Donnelly JP, et al. Defining invasive fungal diseases for clinical research: revised definitions of the EORTC/MSG Consensus Group. Clin Infect Dis 2008; 46:181-21.
27. Ricketti AJ, Greenberger PA, Mintzer RA, Patterson R. Allergic bronchopulmonary aspergillosis. Arch Intern Med 1983; 143:1553-7. (Pubitemid 13033757)
28. Patterson R, Greenberger PA, Harris KE. Allergic bronchopulmonary aspergillosis. Chest 2000; 118:7-8. (Pubitemid 30485478)
29. Khot PD, Ko DL, Hackman RC, Fredricks DN. Development and optimization of quantitative PCR for the diagnosis of invasive as-pergillosis with bronchoalveolar lavage fluid. BMC Infect Dis 2008; 8:73.
30. Herrera ML, Vallor AC, Gelfond JA, Patterson TF, Wickes BL. Strain-dependent variation in 18S ribosomal DNA copy numbers in Aspergillus fumigatus. J Clin Microbiol 2009; 47:1325-32.
31. Mullins J, Seaton A. Fungal spores in lung and sputum. Clin Allergy 1978; 8:525-33. (Pubitemid 9053435)
32. Lass-Flörl C, Salzer GM, Schmid T, Rabl W, Ulmer H, Dierichi MP. Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients. Br J Haematol 1999; 104:745-7. (Pubitemid 29143493)
33. Green BJ, Tovey ER, Beezhold DH, et al. Surveillance of fungal allergic sensitization using the fluorescent halogen immunoassay. J Mycol Med 2009; 19:253-61.
34. Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 2003; 119:854-8. (Pubitemid 37047847)
35. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 9:609-22. (Pubitemid 41383906)
36. Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177:27-34.
37. Greub G, Bille J. Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance. Clin Microbiol Infect 1998; 4:710-6. (Pubitemid 29020864)
38. Nam HS, Jeon K, Um SW, et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 2010; 14:e479-82.
39. McCarthy DS, Pepys J. Allergic bronchopulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clin Allergy 1971; 1:415-32.
40. Chakrabarti A, Sethi S, Raman DS, Behera D. Eight-year study of allergic broncho-pulmonary aspergillosis in an Indian teaching hospital. Mycoses 2002; 45:295-9. (Pubitemid 35279060)
41. Fairs A, Agbetile J, Hargadon B, et al. IgE Sensitisation to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med 2010; 182:1362-8.
42. Tuon FF. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bron-choalveolar lavage clinical samples. Rev Iberoam Micol 2007; 24:89-94. (Pubitemid 47025141)
43. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9:89-96.
44. Pasqualotto AC, Powell G, Niven R, Denning DW. The effects of antifungal therapy on severe asthma with fungal sensitisation and allergic bronchopulmonary aspergillosis. Respirology 2009; 14:1121-7.
45. Vanhee LM, Perman D, Nelis HJ, Coenye T. Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air. J Microbiol Methods 2010; 81:197-9.